Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer

HIGHLIGHTS

• who: Kunal R. Chaudhary from the DepartmentColumbia University University/Montefiore Medical Center, Bronx, NY, USA have published the article: Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer, in the Journal: Scientific Reports Scientific Reports of 17/09/2018
• what: Our study is the first to indicate the potential role of Smurf2 as a common modulator of resistance and to identify Smurf2 as a potential novel actionable target that can improve responses to both cisplatin and radiation therapy in lung cancer.

SUMMARY

Interestingly, the numbers of γ-H2AX . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.